898 related articles for article (PubMed ID: 7523571)
1. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA
J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571
[TBL] [Abstract][Full Text] [Related]
2. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
Baume DM; Robertson MJ; Levine H; Manley TJ; Schow PW; Ritz J
Eur J Immunol; 1992 Jan; 22(1):1-6. PubMed ID: 1370410
[TBL] [Abstract][Full Text] [Related]
3. The functional characterization of interleukin-10 receptor expression on human natural killer cells.
Carson WE; Lindemann MJ; Baiocchi R; Linett M; Tan JC; Chou CC; Narula S; Caligiuri MA
Blood; 1995 Jun; 85(12):3577-85. PubMed ID: 7540068
[TBL] [Abstract][Full Text] [Related]
4. Expression of a functional c-kit receptor on a subset of natural killer cells.
Matos ME; Schnier GS; Beecher MS; Ashman LK; William DE; Caligiuri MA
J Exp Med; 1993 Sep; 178(3):1079-84. PubMed ID: 7688785
[TBL] [Abstract][Full Text] [Related]
5. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
Naume B; Gately M; Espevik T
J Immunol; 1992 Apr; 148(8):2429-36. PubMed ID: 1373169
[TBL] [Abstract][Full Text] [Related]
7. Costimulatory signals are required for optimal proliferation of human natural killer cells.
Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J
J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691
[TBL] [Abstract][Full Text] [Related]
8. Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion.
Jewett A; Bonavida B
Cell Immunol; 1994 Apr; 154(1):273-86. PubMed ID: 7907529
[TBL] [Abstract][Full Text] [Related]
9. Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12.
Naume B; Johnsen AC; Espevik T; Sundan A
Eur J Immunol; 1993 Aug; 23(8):1831-8. PubMed ID: 7688307
[TBL] [Abstract][Full Text] [Related]
10. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
[TBL] [Abstract][Full Text] [Related]
11. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.
Carson WE; Fehniger TA; Caligiuri MA
Eur J Immunol; 1997 Feb; 27(2):354-60. PubMed ID: 9045904
[TBL] [Abstract][Full Text] [Related]
12. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.
Caligiuri MA; Murray C; Robertson MJ; Wang E; Cochran K; Cameron C; Schow P; Ross ME; Klumpp TR; Soiffer RJ
J Clin Invest; 1993 Jan; 91(1):123-32. PubMed ID: 7678599
[TBL] [Abstract][Full Text] [Related]
13. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.
Robertson MJ; Soiffer RJ; Wolf SF; Manley TJ; Donahue C; Young D; Herrmann SH; Ritz J
J Exp Med; 1992 Mar; 175(3):779-88. PubMed ID: 1346796
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of CD16-CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua.
Nishikawa K; Saito S; Morii T; Hamada K; Ako H; Narita N; Ichijo M; Kurahayashi M; Sugamura K
Int Immunol; 1991 Aug; 3(8):743-50. PubMed ID: 1716974
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-15 effectively potentiates the in vitro tumor-specific activity and proliferation of peripheral blood gammadeltaT cells isolated from glioblastoma patients.
Yamaguchi T; Suzuki Y; Katakura R; Ebina T; Yokoyama J; Fujimiya Y
Cancer Immunol Immunother; 1998 Oct; 47(2):97-103. PubMed ID: 9769118
[TBL] [Abstract][Full Text] [Related]
16. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.
Dadmarz R; Bockstoce DC; Golub SH
Lymphokine Cytokine Res; 1994 Dec; 13(6):349-57. PubMed ID: 7535569
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells.
Warren HS; Kinnear BF; Kastelein RL; Lanier LL
J Immunol; 1996 May; 156(9):3254-9. PubMed ID: 8617947
[TBL] [Abstract][Full Text] [Related]
19. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
Saito S; Morii T; Enomoto M; Sakakura S; Nishikawa K; Narita N; Ichijo M
Cell Immunol; 1993 Dec; 152(2):605-13. PubMed ID: 7504983
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.
Voss SD; Sondel PM; Robb RJ
J Exp Med; 1992 Aug; 176(2):531-41. PubMed ID: 1500859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
